Edouard: 0:01

38% of the whole pediatric population is going to the emergency room every year. And we understood that around 40% of those E.R. admissions are not necessary. Well, medtech is more about how to create a tool that will help both doctors at large to better do their work to make it more efficient to do something that was not possible before. Medtech was something that we didn't know at first, so we had to learn everything from it. So we get into contact with different people. You try to understand what it is. At first. You need to understand the medical field, the importance of doctors, hospitals, different stakeholders that you have around the table. We have different added value that the others don't have. Mainly that would be the advanced analytics that we are using through the different platforms we have. What we aim to do is also to bring an extra layer around the parents.

Amy-Caroline: 0:53

Hi Odooers, welcome back for another episode of Planet Odo. Did you know 38% of the kids in the US are visiting emergency rooms or admitted to the hospital every year, and yet 50% of these events are avoidable. Luckily, connected technology has emerged as a game changer in healthcare, holding the power to revolutionize our approach to medicine. In today's episode, we're thrilled to be joined by a visionary of the healthcare industry Edouard Carton, the CEO of Gabi Smartcare. He and his co-founder have developed an ingenious wearable device specifically designed for children aiming to revolutionize health monitoring and preventative care practices. In an impressive span of seven years, they have successfully penetrated the highly exclusive MedTech market, acquiring comprehensive knowledge of the industry from the ground up. From conceptualization to prototype development, they're pursuing their mission on a daily basis with the help of Odoo. All right. So welcome. Thank you for joining me at the studio today. It's lovely to have you.

Edouard: 1:52

Yeah, thank you for having me today.

Amy-Caroline: 1:54

Can you start by telling us a little bit about Gabi Smart Care and yourself?

Edouard: 1:59

Sure. So Gabi Smart Care is a company active in the medtech industry. So we are developing some solutions for pediatrics, specifically in with medical device. And the company is existing now for the past seven years. So I'm one of the two co-founders of the company and I'm the COO today of the company for the last five years now and taking more responsibility about regulatory also all the operations in here in Belgium. My associate is based in the US.

Amy-Caroline: 2:31

How did this project come about? What inspired you both to collaborate on this product?

Edouard: 2:37

Well, it's more about my co-founder initially, so he had an experience with his So when she was born, some days after birth, she had the bronchiolitis, which is not that bad at first. However, at that moment, she had to go to the hospitals. She got monitored with a lot of sensors and so on. It was a lot of anxiety also for the parents. So hopefully today she is okay. But at the time when she was released from hospitals, there was not a lot of follow up for the parents. Therefore, there was a lot of also anxiety for them in the next weeks, month and each time there was an issue, a health issue for the child, they were like quite well, they have a lot of thought about what what could be done here. Is it quite serious or not? Do we have to go to the hospitals? And eventually they went there 3 a.m. in the morning. Well, doctor says that's okay. You can come back tomorrow to your doctors or no worries. It's nothing serious, but it puts a lot of burden on the family, on the couple. So eventually he had the idea. My co-founder John had the idea of, well, this should be something there for pediatrics, helping me to have a better view of what could be done with my child. There are so many things out there for adults, so there must be something there. So he said, well, let's try and have a look to what's on there to help more parents like like me to go through those difficult period.

Amy-Caroline: 4:04

That's really nice that the project came from something so personal as well into it because it's not just important for parents everywhere, but also for yourselves. So that's really nice. And so how does it actually work? How does the band work? How? Tell us more about the product.

Edouard: 4:25

Sure. So the product, the one we just developed is called pediatric. So it's a mix of different subsystems. It's part of it's a mix of the hardware and software. So let's talk about the hardware. The hardware, The device itself is placed on the baby's arm. So it's a device for children from 0 to 12 years of age. So the device is placed on the baby's arm, communicates with the tablet, which is also released with the product that you receive as a parent, caregiver, as we call them. So you receive the band for the baby, for the the patient you receive also the tablet for the parents. So the different information are recorded by the band and send over to the tablet so you can have a look to what's recorded and all the information are then sent to a cloud from which HCP. So health care professionals doctors can have access to through a dedicated platform. We call it Gabi Analytics, so they can have a view of the different parameters. So the parameters that are recorded, so measured and recorded on the child are spo2. So oxygen level blood, oxygen, pulse rates, respiratory rates and movement. So you place the device on your child when, for example, he or she goes to bed. You record the different information through the night and then on the next day you have the different information that will be available for the doctors. And so it's like kind of a monitoring remotely. So from home for some population of pediatrics.

Amy-Caroline: 5:51

And so what who who is your target Exactly. Of course you your product is for children. But are you focusing on a certain target right now?

Edouard: 5:59

Well, so it's for pediatric, which is quite large at the moment. For example, the FDA in the US, they divide that in neonates, infants and children, which is like neonates, is up to 20 days of of life and then up to two years of age and then up to 12. So this is the whole population we have in terms of, let's say, health issues. Definitely it's at first it could be dedicated to to children who have got some health issues. So mainly from a cardiac or respiratory issues, definitely. But they are not in a critical state, which means that they don't have to stay in hospitals. However, it would be a good solution for them to have a good follow up at home, especially for doctors. They say, well, I don't see your child staying here. But it would be good to have some more information for the next weeks, months whatsoever. But I don't require him to stay here. So this is the population that we are focusing on. However, we don't want to stop there because there is also a whole lot of other population. We know that parents are quite worried about the child health and we would like also to make it available to those parents, but also the child, just not specifically as a follow up tool, but also at the end as a prevention tool. So well, those are the different kind of population that we would like to to target.

Amy-Caroline: 7:21

Okay, great. And how did this all get started? So you had this amazing idea and where did you start from creating the prototype to finding funding to working with partners, building your network? Can you tell us more about the process there?

Edouard: 7:35

Yeah, sure. When we started the product, the project with John, so it was eight do? What kind of product should meet the parents needs? So initially we started to the parents say, Well, do you have the same issues and so on? Well, eventually after that we say, well, yes, there is. There are a lot of people who are in the same case. Okay, well, what can be used as a device there, to get some information? Then we start to think about the form factor, the type of sensor that we need to integrate that device, color, the size. You start with all those things and you start with the prototype. So we were the two of us at the time and we got some help with another prototyping company from Brussels initially, and then we started to iterate to collect information, can we have the correct information and so on. But quickly, we had some discussions with another company from Brussels. They are working in the consultancy more the regulatory part of medtech industry mainly, and we didn't know anything about MedTech at the time. So do we have to be medical or not? We were like, No, not really. I mean, we're not sure. And after discussing well, it depends of what we call the intended use. And the intended use is really what is your product will, what is going to do, what population, what case, and so on. So we said, well, we have that typical case of of monitoring some physiological parameters, vital signs and so on and say, well if that's the case, you will be a medical device. I mean, you have to that's the rule. Okay? And then you start understanding what it what it is at that moment. You say, well, I don't want to be a medical device. It takes so long, so much money, it's so complex. So we said, Well, we started we tried to stay as a non medical device, so we did some more prototypes. We started to hire the first people in the company. Then there was the Covid happening, which was at the moment a problem for us because we were also trying to raise funds and we had two investors already there. But when the Covid hit and the two investors said, well, it's going to be a good time for us, say, okay, we still have some money in the account on the account, but we need to find something. So we iterate on the solution with regards to the form factor or the placement of the product on the baby. And we say, well, we try to do a product that we're going to sell and see if we can get some money from it. But doing this, we also understood better the market. We got closer to the doctors, physicians, so all the HCPs, the caregivers and so on, and we understood that well, yes, there is a need for the parents as a non-medical product, but there is clearly a a need for a medical device. So, we pivot at that moment at the end of Covid, and we had to change the way we we did the product because to make sure that we follow different kind of regulations, standards, some norms and so on. And at that moment, we change a bit the, let's say, DNA of the company. We increase the number of people inside the team. We managed to raise some funds and then you have different steps of development that you need to follow. And then another prototype there some some test, internal test, some validation, clinical trials and so on until final submission. And there we are.

Amy-Caroline: 11:02

And there you are. And so for the clinical trials, the work that you've done also working with other physicians worldwide.

Edouard: 11:13

So initially, yes, it was in Belgium. So we started a first clinical trial with three sites in Belgium. The main goal of that one was to collect information, collect data and see if we can improve the algorithm that we have built at that moment. We did that on a bit less than 100 children. It was in hospitals and after that we quickly made contact with the US. We are now part of the J Labs, which is an incubator from the Johnson and Johnson, and we got some contacts. We increased our network and we got in touch with different people and organizations in the US. So, at that moment we, we were having the idea of having another clinical trial and this one would happen also in the US. So, the second one we did was partially in Belgium and in the US. So four sites, two in Belgium to the US on also 100 children. And this was a different kind of clinical trial, more to be I mean to use the device at home with parents but prescribed by a doctors. It was prescribed to parents of children who have different kind of cardiac issues or respiratory issues, bronchiolitis, RSV or those kind of pathologies. And for which the doctors would say, well, I can see an advantage for those children, this population to have your device and they would prescribe it and they would enter the clinical trial. Apart from that, we did other validation trial. So those ones are important for us to submit the certification that we would like to. So to be able to do that, you have to collect data that you need for submission, either to the FDA in the US or in Europe. But you need these data to say, well, we validate the device and we prove that the device is working on a human subject. And those clinical trials have been performed in the US as well. Apart from that, we have another one. It's more it's not clinical trials as such, but it's more clinical research. So we got in touch with different centers in the US who are quite interested in having this device for a certain type of population, but for another goal that they have. But they would need another tool and this tool corresponds exactly to what they need. Apart from that, it's also a last one in France with the hospital in Paris, we are in the middle of a clinical trial also where they are collecting different kinds of information for sleep analysis. There was the responsible there, the doctor for who is really interested also in having this device to be able to collect those information on pediatric population, which was not the case before on an easy way. So she was looking for it. We got into contact with her and said, Well, I'm interested in your device. Would it be possible to integrate that in a clinical trial in a hospital? And also, yeah, there we are. We have, I think around four patients or five patients per week for the last three months now. So it's a lot of data for us, but it's quite important for them as well. So a win win situation and they are able to use our device.

Amy-Caroline: 14:23

Absolutely. That's amazing that your network is so strong even after only seven imagine. Could you tell us a little bit more as well about the medtech industry in general and some of the main aspects that someone needs to consider when entering this market?

Edouard: 14:45

Sure. So again, medtech was something that we didn't know at first, so we had to So you get into contact with different people, you try to understand what it is. At first. You need to understand the medical field, the importance of doctors, hospitals, different stakeholders that you have around the table. But well, MedTech is more about how to create a tool that will help support doctors or hcp's at large to better do their work to make it more efficient to do something that was not possible before. It could be also used by the patient itself. At some point you can also see it how to bring the health of the patient on the patient itself so you don't have to go to a specific place to perform a certain test. But you could do that test at home with the right tools. So this is about medtech, definitely. But, what's really important as it is the case for pharmaceutical industries is the whole regulatory field. So you need to understand what kind of regulatory you need to follow the standards, the norms and so on, what's important for your device. And everything is dictated by the main thing, what they call the intended use. So the use case and it's quite clear how it is defined and based on that definition, you will enter in different boxes if you want.

Amy-Caroline: 16:05

This also depends, I suppose, on where you're marketing the product as well. Between Us, Europe, you may have differences that you also have to be.

Edouard: 16:13

Yeah, clearly. So you have different regulatory landscape depending the on the For example, in Europe you have some institution wide and high level and those ones are regulating the whole market in Europe. And below that you have what we call the notified bodies, which are independent companies who are able to review what we call the technical file, which is globally the whole work that you've performed that you send to that notified body and they have a certain time to review everything and make sure that you comply with all the standards and norms and so on. In the US it's completely different. You have the FDA, so the federal.

Amy-Caroline: 16:57

The food and drug, the.

Edouard: 16:58

Food and Drug Administration, sorry. So you have the FDA, the Food and Drugs Administration, which is regulating everything there from medicines, I mean, to medical devices. And so MedTech is definitely entering in that aspect. So we don't have different kind of independent company. We directly have contact with the FDA and they review everything. So there are no other companies they're interacting in between. No, everything is done by the FDA. And even if in Europe or worldwide, you have some norms and standards does apply also in the US. But on top of that, you have some guidance from the FDA on plenty of different subjects. It depends on your device, what kind of guidance you will use, but they are there to help you building your product and making sure that you are meeting their requirements. So that's for the US. But you have different kind of regulatory institution worldwide. In Japan, it's different in Brazil, also Australia. So they are all kind of different. But let's say the main ones, or at least for us at the moment, it's mainly the FDA in the US and. What we will try to have is the CE mark in the Europe through notified bodies and so on.

Amy-Caroline: 18:20

And then maybe expand beyond that.

Edouard: 18:25

We'll see. Yes. But the US is still a big part of the cake. And I mean, it's a big mission in Europe as well. It's quite huge, of course.

Amy-Caroline: 18:35

So how would you say that your product or your solution really distinguishes

Edouard: 18:44

Well, at first, as we are a medical device, there are not so many medical Reasons are you could see it as a riskier population, which makes the development a bit more complicated. Not risky, but more complex. If you start from scratch, you say, well, I'm not sure. I don't want to go in that field. So numbers of competitors as a medical device for pediatric is quite low. However, we have different it added value that the others don't have. Mainly that would be the advanced analytics that we are using through the different platforms we have. So there is one the analytics platform we are using for HCPs. We want to to make it as comprehensive as possible to develop with doctors for them. So it's clearly where we want to go in the analytics, in the prevention, using all the data to make sure that we can extract the best of it and make it more efficient to be able to prevent eventually some issues. So that's that's one thing I would say. The other thing also is the medical support that we would like to bring to the parents. So, I explain how the product works earlier on with the different subsystems. But what we aim to do is also to bring an extra layer around the parents. So when the parent will use the device with the children, they will be able also to have access to a virtual care center. That's how we call it. And what was missing, if I come back to the story of John, was, well, my daughter is out of hospitals, I have a problem. I don't know what to do. My doctor is not there. Well, last option. I go to the emergency room. I end up there and telling me that's nothing and I go back home and it is very complicated on the professional life, family and so on. So there we understood also that what would be important is to be there for the parents and make sure that we are there to help them answer their questions and try to lower any anxiety if there is. So the solution will allow parents to get in touch with that virtual care center and get in touch with either an HCP. So it could be a nurse, it could be a physician pediatrician whatsoever. But someone on the other side of the line that can say, well, what's the issue? Tell me. And so based on the different information that were collected on the patient for the past days, weeks on top of the electronic medical record that the doctor may have access to and the feedback from the parents at that moment saying, well, my child was okay yesterday. No, I see that there could be an issue. I'm not sure what it is, but I'm quite worried. And so with these three supports, the HCP will say, well, based on what I understand and what I see, what you're telling me, this is what I recommend you to do. And it can I mean, the person can say, well, take some medicines or just don't do anything. It's okay, wait for tomorrow and we'll see how your child is. But it shouldn't be. It shouldn't be a problem or well, based on what I see, it would be, I think, better for you to go to the emergency room and. This is clearly an extra service that really is iportant for the parents, but also for the whole environment. So I think, yeah, this is a quite a big differentiator compared to the other competitors that are not using that kind of of product. Medical device monitoring pediatrics at home are not a lot. I mean, we can't count them, maybe three of them worldwide. And there are different types of products not doing exactly what we are doing or you have different kind of products which are non medical device. So you have a different kind of accuracy. You have pros and cons, but definitely it's not a medical device, so the accuracy is not there. So the doctors eventually will say, well, I don't know, it's a gadget or not. What's the accuracy? I can't base my diagnostics or any conclusion I have on my patient based on that those tools so they won't use it. And this is not what we want to do. We want to be there for parents, but also for physicians and make sure that we are helping everyone there.

Amy-Caroline: 23:01

And not only that, but I suppose with the type of service you can provide a huge financial advantage for the parents as well, not you. Maybe we can avoid some unnecessary trips to the emergency room, things like that, especially in the US market where that's a huge consideration as well.

Edouard: 23:26

Yes, definitely. One of the objectives that we have is also to decrease the number of patients going to the emergency room. So on the financial aspect for the parents, of course, you don't want to end up in hospitals for nothing, have costs for nothing. But you didn't know even at start. But the life or the health of your little one has no cost mainly. But you want to try to to to lower that cost. How it's possible. Well, with the right tools and making sure that you take the right decision. So at the moment we know that around 38% of the whole pediatric population is going to the emergency room every year. So in the US, I think it's around 30 million children going there. And we understood that around 40% of those E.R. admissions are not necessary, so they end up there. What is it? Well, don't worry. It's nothing. Go back home. Well, that's not efficient. That's not efficient for the parents. Yes, it costs some money. It takes some time. It puts a lot of burden on on the family. But for the hospitals, which is a really important stakeholder, of course, it's not efficient either because it will be a lot of costs spent by the the hospitals, by the doctors, But also you will use some rooms, some beds for for for patients who are not in critical state or actually it's it's nothing major, no health issue compared to others who are queuing there with real issues. And so. You have a lot of line. I mean, queue behind in front of the hospitals with all the patients and you want to reduce that. So you want to say, well, all the people who are really sick come and the others not. You can't do that. So how can you improve that situation? Again, with the right tools and taking the right decision, but trying to have this to take this decision not in front of the doors of the hospitals, but outside and maybe at home already and making sure that, don't worry, stay there. There is nothing to worry about. And for the others, we'll go to the hospitals because you need it. This is clearly the goal that we are seeking.

Amy-Caroline: 25:42

When you decided to first work with Odoo, were you really solely thinking about that you would potentially expand as well, considering that we're a full suite software?

Edouard: 25:57

When we started to think about Odoo, initially we wanted to have a good solution That was the first point. However, we understood that what an ERP, for example, at large could be and could support us with. And it's quite difficult to go from one software to another to another. I mean, it's quite difficult to change the whole team. So the goal is really to make sure that you are making a choice not only for the next year but make it longer and make sure that you have different options that you can integrate directly in your portfolio, in your company and for the entire team. So when we check the different solutions on the market, Odoo they have the inventory, stock management for sure, but they also have the different other features that we need on the next steps. At the moment I said that we don't have the product on the market yet. However, this is the target for 2024. At that moment, we will include different other aspects such as invoicing, sales, supply chain procurement and still a lot of more stock management and so on. And Odoo has all those features. We say, well, then let's think about the next years and not directly for the next six months. And this seems to be the right solution helping us for the future to integrate all these aspects in the right manner. Because we start with this and we will know how to use the product now and it's going to be easier to adapt for. I mean, when we integrate the other features within the team.

Amy-Caroline: 27:29

Okay. So Odoo will be able to scale up with Gabi Smart Care.

Edouard: 27:32

Yes. Yes. I think that's that's what we we intend to.

Amy-Caroline: 27:36

So Odoo will grow with you as as you guys expand. So how can someone actually get one of these devices for their children?

Edouard: 27:45

At the moment they can't because we just finalized the the product. So we finalized the product, but we submit also to the FDA a couple of weeks ago, which means that we cannot put it on the market itself. However, we can assist the different mentioned earlier, but the clinical facilities for some research projects, clinical trials, that's feasible, how the patient will have access to it once it's going to be on the market. Well, you have two examples. The first one would be Gabi Smart Care is known by your physician pediatrician, and he's interested in having your child, the patient, to be monitored for a certain amount of time and to get some data out of it. But at home, because there is no need to keep that patient in hospitals anyway. But it would be good to have some information for the next couple of months or more to do it at home. So it will give you a prescription and you will be able to go on the website and say, well, this is my prescription. I would like to order one of the the device pediatric and he will receive the the box with the whole the whole product. That's the first case. There is another case where as a parent. You are interested in that technology. You would like to have a medical support from the device, but also from an HCP there. But you don't have a prescription at first. Well, the idea would be to go on the website and say, well, you have to fill in some questionnaire to make sure that, you or your patient, is available to to get the device. It's not available. I'll start that. Sorry. So the second option would be as a parent and you are interested in that technology and to get the medical support from HCPs, from the product and you would be entitled to get that product. But you first have to fill in a questionnaire and a doctor behind that needs to check your questionnaires filled in and making sure that, yes, it would be you would fit in the program and you would be allowed to get the device and then you would receive the device at home and you would still have access to the virtual care team, where in my first example, well, your pediatrician will have access to the data of your child. So he will be able to follow up. But if it's not your pediatrician who prescribed you the device, you still have access to that extra layer service of medical support through the medical care team.

Amy-Caroline: 30:19

Okay. Amazing. That's good to know for any of our listeners who are interested. And so what are the next steps for Gabi Smart care? What are you envisioning for your company coming up?

Edouard: 30:31

Well, if we take the story of the company from scratch, we started in Belgium. We understood European market. We also were interested in the US. We understood that US would be at first our main market. And from that moment we discussed internally also with the board and so on. And we end up with the conclusion that it would be good to have to be in the US physically. So last year my associate co-founder John moved to the US with the whole family. So he's now living in the US. But just to prepare that important part of the future of the project because it would include some fundraising market access, be close to the market of course, but also to be close to physicians, to centers, hospitals and so on. So, this is where we are at the moment. We submitted the certification to the FDA and we are in the middle of a fund raising also to support us for the next steps. These next steps will be clearly to be ready for manufacturing and putting the device on the market, making sure that we are targeting the right population and in the right way. And then, we are also thinking of, not new product, but new features that we are working on at the moment. But in the MedTech, everything takes a lot of time. The regulatory burden there is mandatory, yes, but it's there and it takes time for development, for raising funds. But definitely this is where we want to go at first, is to go to the US, put the product on the market and make sure that we are helping as many patients as possible and see how we can tune the product to even meet more needs of of this population. But we have big ambitions on the next years.

Amy-Caroline: 32:24

Well, then as a last question, in general, what do you see for the future of that may come out on the market? Because as you said, of course, every little thing that you design, it takes a lot of time and you have to be really careful about following the regulations, which of course is just important for the quality of the service, the product and for the health of the child. Do you see anything else or envision anything else that might be happening just generally in MedTech for pediatrics right now?

Edouard: 33:00

I mean, medical device in the pediatric population is is not easy because it's So it seems that you have this innovation that took place for the adult market. So you have plenty of devices there that we can use. You don't have those ones for for the babies, which makes sense. Also. However, we are getting there. I mean, I don't speak about some gadgets, if I can say it, but really medical devices that can be accurate and support the population. So it's important also for the manufacturers to distinguish medical device to non medical device because all the parents, people, they don't know the difference. I mean, they don't know the difference. They can know the difference, but it's not like, okay, this one, I can buy them in the shop. This one is a medical device. This one not I'm not sure what it implies, but could be good. It could, but. But I'm not sure about it. So we need to make sure that we do the right marketing around it. But for the future of medtech, for pediatrics, I think the communication will be more than important to the parents because it's easy to bring I mean, to give data, it's another one to to not cross the fine line between, let's say, health information and helping parents to understand that and giving health data just for the sake of them. And then the parents will be, well, I'm quite worried about what I what I see. But they don't have any medical background. And that's the difficulty for them. It's just to make sure that, we are providing the right communication, we help and we support parents, but we also guide them to understand those data, making sure that it doesn't raise anxiety. But actually we are there to help them and for the support. So I think that for the future it's really important. I don't see for the next ten years so many sensors surrounding pediatrics because it's regulated, it's really complex and it's a difficult market also. And when you have a medical device, either you really helping the doctor with the caregiver. But if you want to do something only for parents as a gadget, well, then it's it's different. It's not really a medical device. So you will have a lot of gadgets. Yes. You will have a lot of of devices there for babies and targeting pediatric population. It's a big market. Yes. But in terms of medical device, I don't see it booming with different and plenty of of kind of sensors and devices out there. All right.

Amy-Caroline: 35:37

So let's imagine I'm someone who wants to break into the medtech industry. Where do I even get started?

Edouard: 35:44

I think the first spot would be to make sure that, you know, the regulatory So what are the different institutions? Where should you want to go? Us, Europe, because it's quite different in terms of regulations. I think that's that's the first part. And making sure that being a medical device, I mean, developing a medical device, what does it imply in terms of cost, in terms of time of development? Because it's day and night compared to a non medical product. That would be the first point, making sure that you understand the needs of the patient for sure, but also making sure that you include the whole stakeholders and mainly doctors, physicians be close to hospitals because they are the experts. They know the field, they know their patients, and they know what could be the future and what what's good to be there to help them in their work. And then the last point would be make sure to surround you with with experts. It's kind of an easy one. But those people some people are costing a lot of money. Yes. Butyou need that experience, these expertise to make sure not to to do the wrong choices, especially within the regulatory field, because it's easy to take one direction and to have different conclusions that you really wanted to initially. So it means that the consequences can be quite big or bad if you if you took the the wrong path because of a lack of experience and it could be for regulatory but also for different fields. So I would say that point.

Amy-Caroline: 37:09

So of course Gabi Smart Care managed to do this and throughout your journey,

Edouard: 37:17

Well, as all the tech companies, I think that making sure to submit your Raising funds also for something which was not a company initially, but I think the main one would be to after those seven years, we are still here. I mean not on the market yet, but evolving, developing a product and making sure that we manage to gather some people around us and a great team to help us and to make sure that we are targeting the same main objective. So on a day to day basis, they are supporting us and making sure that we are developing the right solution. So yeah, it's nice to see to be surrounded with the same period and single and people who are really motivated within our team. So I think that's clear. One of the main objective that I'm proud of and making sure that I'm still there also with my co-founder after seven, eight years and we also very good friends. I see so many cases in which this friendship ends because of difference of opinions of whatsoever.

Amy-Caroline: 38:19

Amazing. Well, it was a pleasure to have you visiting us today. I think that's about it for our time. But it's really amazing that you're creating this product where you're focusing and service and solution that you're focusing on, of course, the quality of material, how you're gathering data, but also you're trying to prevent the misuse of this data or misinterpretation. And so that care that you're giving into this solution is really amazing. So I just wanted to say that for Gabi Smart Care and Odoo is really happy to be collaborating with you. So thank you very much. Thank you. Thank you. Thank you for joining us today. We hope you found our exploration of the medtech industry and the exciting future of healthcare advancements. Insightful. If you're hungry for more captivating episodes, be sure to check out our other thought provoking discussions. Until then, cheers.